ArticlePloS one2013
Colorectal cancer patients with low abundance of KRAS mutation may benefit from EGFR antibody therapy.
Shaorong Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticlePloS one2013
Shaorong Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.